- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.46 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x MTA: 5'-DEOXY-5'-METHYLTHIOADENOSINE(Non-covalent)
- 1 x 01: N-(6-amino-5-methylpyridin-3-yl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide
01.2: 15 residues within 4Å:- Chain A: Q.317, S.318, L.320, V.334, F.335, E.443, L.445, S.447, E.452, V.511, F.585, S.586, W.587, F.588
- Ligands: MTA.1
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:Q.317, A:L.320, A:L.320, A:V.334, A:F.335, A:F.335, A:F.335, A:E.443, A:F.588
- Hydrogen bonds: A:L.445, A:E.452, A:S.586, A:F.588
- pi-Stacking: A:W.587
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 7 residues within 4Å:- Chain A: W.194, D.227, R.228, L.230, S.484, H.518, T.554
Ligand excluded by PLIPEDO.4: 3 residues within 4Å:- Chain A: M.324, D.325, N.326
Ligand excluded by PLIPEDO.5: 5 residues within 4Å:- Chain A: A.167, P.168, E.169, W.196
- Chain B: A.175
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: E.475, Y.476, T.477, E.564, V.566
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: I.226, W.229, L.230, R.264, L.268
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: F.48, P.128, W.160, Q.271
Ligand excluded by PLIPEDO.9: 6 residues within 4Å:- Chain A: R.60, E.61, F.62, K.68, Q.74, Q.117
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: G.638, R.639, S.640, Y.641, T.642
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: Y.543, C.544, T.545
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: L.316, S.318, C.495, Y.510
Ligand excluded by PLIPEDO.13: 3 residues within 4Å:- Chain A: K.401, S.425, S.426
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: V.423, V.424, S.425
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: K.93, L.94, L.131, P.133, R.162
- Ligands: EDO.16
Ligand excluded by PLIPEDO.16: 7 residues within 4Å:- Chain A: N.29, K.93, L.94, P.96
- Ligands: EDO.15, EDO.17, EDO.21
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain A: P.96, R.99, N.135
- Ligands: EDO.16, EDO.20
Ligand excluded by PLIPEDO.18: 7 residues within 4Å:- Chain A: E.137, D.138, N.139, T.140, W.196, N.199, L.203
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain A: F.54, Q.74, Q.117
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain A: N.135
- Chain B: K.153, A.176, Q.177
- Ligands: EDO.17, EDO.21
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain B: D.134, K.153, D.154
- Ligands: EDO.16, EDO.20
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain B: N.198, G.215, C.216, G.220, Y.221, P.223
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, K.M. et al., Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP -Deleted Cancers. J.Med.Chem. (2024)
- Release Date
- 2024-04-24
- Peptides
- Protein arginine N-methyltransferase 5: A
Methylosome protein 50: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.46 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x MTA: 5'-DEOXY-5'-METHYLTHIOADENOSINE(Non-covalent)
- 1 x 01: N-(6-amino-5-methylpyridin-3-yl)-2-[(2R,5S)-5-methyl-2-phenylpiperidin-1-yl]-2-oxoacetamide
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cottrell, K.M. et al., Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP -Deleted Cancers. J.Med.Chem. (2024)
- Release Date
- 2024-04-24
- Peptides
- Protein arginine N-methyltransferase 5: A
Methylosome protein 50: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B